Avantor, Inc. (NYSE:AVTR) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC grew its position in Avantor, Inc. (NYSE:AVTR) by 89.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,715 shares of the company’s stock after acquiring an additional 1,285 shares during the quarter. GAMMA Investing LLC’s holdings in Avantor were worth $70,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of AVTR. Jennison Associates LLC lifted its position in Avantor by 113.0% during the 1st quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock worth $63,857,000 after acquiring an additional 1,325,026 shares during the period. Swedbank AB purchased a new position in Avantor in the 1st quarter valued at $2,707,000. Diversify Advisory Services LLC acquired a new position in Avantor in the 1st quarter valued at $908,000. Oliver Luxxe Assets LLC purchased a new position in Avantor during the 1st quarter worth $1,538,000. Finally, BNP Paribas Financial Markets lifted its stake in shares of Avantor by 42.4% in the 1st quarter. BNP Paribas Financial Markets now owns 309,394 shares of the company’s stock worth $7,911,000 after acquiring an additional 92,098 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Barclays boosted their price target on shares of Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and cut their target price for the stock from $30.00 to $23.00 in a research note on Wednesday, July 10th. Evercore ISI dropped their price objective on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Robert W. Baird raised their target price on Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a report on Monday, July 29th. Finally, UBS Group decreased their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $28.00.

Avantor Stock Down 0.7 %

AVTR stock opened at $24.88 on Wednesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $28.00. The firm has a market capitalization of $16.90 billion, a PE ratio of 63.79, a P/E/G ratio of 2.93 and a beta of 1.33. The company’s 50 day simple moving average is $25.65 and its 200-day simple moving average is $24.34.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. Equities analysts expect that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at $740,372.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.50% of the stock is currently owned by corporate insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.